Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studies
Guardado en:
Autores principales: | Paul Middleton, Mark P Lythgoe, Catherine Hsu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ce272f975c7949d28065c1e009bce97d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management options in decompensated cirrhosis
por: Shah NL, et al.
Publicado: (2015) -
Associations Between Alcohol Use and Liver‐Related Outcomes in a Large National Cohort of Patients With Cirrhosis
por: Meredith M. Pearson, et al.
Publicado: (2021) -
Impact of medical therapies for inflammatory bowel disease on the severity of COVID-19: a systematic review and meta-analysis
por: Mohammad Shehab, et al.
Publicado: (2021) -
Natural history and management of primary biliary cirrhosis
por: Al-Harthy N, et al.
Publicado: (2012) -
Systemic vascular resistance in cirrhosis: a predictor of severity?
por: Gaduputi V, et al.
Publicado: (2014)